Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mast cells on the mind: new insights and opportunities.
Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.
Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study.
Nigella sativa amliorates inflammation and demyelination in the experimental autoimmune encephalomyelitis-induced Wistar rats.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Genetic predictors of relapse rate in pediatric MS.
Retinal Cell Degeneration in Animal Models.
Tertiary lymphoid organ development coincides with determinant spreading of the myelin-specific T cell response.
Immunomodulation by Transplanted Human Embryonic Stem Cell- Derived Oligodendroglial Progenitors in Experimental Autoimmune Encephalomyelitis.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures.
Metric Optimization for Surface Analysis in the Laplace-Beltrami Embedding Space.
Oxygen cost of walking in persons with multiple sclerosis: disability matters, but why?
The role of Toll-like receptors in multiple sclerosis and possible targeting for therapeutic purposes.
Simvastatin in patients with progressive multiple sclerosis--Authors' reply.
Exercise in the community for people with multiple sclerosis -- a follow-up of people with minimal gait impairment.
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
New magnetic resonance imaging biomarkers for the diagnosis of multiple sclerosis.
Relapses and disability accumulation in progressive multiple sclerosis.
Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation.
Multiple sclerosis: IgM bands indicate reduced risk of PML on natalizumab.
The association of -475 and -631 interleukin-2 gene polymorphism with multiple sclerosis in Iranian patients.
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
Optical coherence tomography shows retinal abnormalities associated with optic nerve disease.
Pages
« first
‹ previous
…
359
360
361
362
363
364
365
366
367
…
next ›
last »